Small molecule · developed by Harmony Biosciences Management
HBS-104 is an investigational small-molecule drug studied in Sleep Deprivation.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT07848659 | Phase 1 | Sleep Deprivation | Recruiting | HRMY |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Sleep Deprivation
Updated Oct 18, 2026. Something wrong or missing? Report it on the HRMY page.
See HRMY's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
HRMY catalysts and pipeline →